Bone Marrow Features and Clinical Findings in Chronic Myeloid Leukemia - A Comparative, Multicenter, Immunohistological and Morphometric Study on 614 Patients

References

• Kantarjian H. M., Deisseroth A. S., Kurzrock R., Estrov Z., Talpaz M. Chronic myelogenous leukemia: a concise update. Blood 1993; 82: 691–703
   PubMed Web of Science ®Google Scholar
• Dickstein J. I., Vardiman J. W. Hematopathologic findings in the myeloproliferative disorders. Semin. Oncol. 1995; 22: 355–373
   PubMed Web of Science ®Google Scholar
• Cervantes F., Rozman C. A multivariate analysis of prognostic factors in chronic myeloid leukemia. Blood 1982; 60: 1298–1304
   PubMed Web of Science ®Google Scholar
• Kantarjian H. M., Smith T. L., McCredie K. B., Keating M. J., Walters R. S., Talpaz M., Hester J. P., Bligham G., Gehan E., Freireich E. J. Chronic myelogenous leukemia: a multivariate analysis of the associations of patient characteristics and therapy with survival. Blood 1985; 66: 1326–1335
   PubMed Web of Science ®Google Scholar
• Sokal J. E., Baccarani M., Russo D., Tura S. Staging and prognosis in chronic myelogenous leukemia. Semin. Hematol 1988; 25: 49–61
   PubMed Web of Science ®Google Scholar
• Cortes J., Kantarjian H. M., Giralt S., Talpaz M. Natural history and staging of chronic myelogenous leukaemia. Bailliere's Clin. Haematol. 1997; 10: 277–290
   PubMedGoogle Scholar
• Burkhardt R., Bartl R., Jaeger K., Frisch B., Kettner G., Mahl G., Sund M. Chronic myeloproliferative disorders (CMPD). Pathol. Res. Pract. 1984; 179: 131–86
   PubMed Web of Science ®Google Scholar
• Lorand-Metze I., Vasallo J., Souza C. A. Histological and cytological heterogeneity of bone marrow in Philadelphia-positive chronic myelogenous leukaemia at diagnosis. Br. J. Haematol. 1987; 67: 45–49
   PubMed Web of Science ®Google Scholar
• Georgii A., Vykoupil K. F., Buhr T., Choritz H., Döhler U., Kaloutsi V., Werner M. Chronic myeloproliferative disorders in bone marrow biopsies. Pathol. Res. Pract. 1990; 186: 3–27
   PubMed Web of Science ®Google Scholar
• Thiele J., Fischer R. Megakaryocytopoiesis in haematological disorders: Diagnostic features of bone marrow biopsies. An overview. Virchows Archiv A Pathol. Anat. 1991; 418: 87–97
   Google Scholar
• Nafe R., Georgii A., Kaloutsi V., Fritsch R. S., Choritz H. Planimetric analysis of megakaryocytes in the four main groups of chronic myeloproliferative disorders. Virchows Archiv B Cell Pathol 1991; 61: 111–116
   Google Scholar
• Thiele J., Titius B. R., Kopsidis C., Fischer R. Atypical micromegakaryocytes, promegakaryoblasts and megakaryoblasts. A critical evaluation by immunohis-tochemistry and morphometry of bone marrow trephines in chronic myeloid leukemia and myelodysplastic syndromes. Virchows Archiv B Cell Pathol. 1992; 62: 275–282
   Google Scholar
• Buhr T., Choritz H., Georgii A. The impact of megakaryocyte proliferation for the evolution of myelofibrosis. Histological follow-up study in 186 patients with chronic myeloid leukemia. Virchows Archiv A Pathol. Anat. 1992; 420: 473–478
   Google Scholar
• Bartl R., Frisch B., Wilmanns W. Potential of bone marrow biopsy in chronic myeloproliferative disorders (MPD). Eur. J. Haematol. 1993; 50: 41–52
   PubMed Web of Science ®Google Scholar
• Dickstein J. I., Vardiman J. W. Issues in the pathology and diagnosis of the chronic myeloproliferative disorders and the myelodysplastic syndromes. Am. J. Clin. Pathol 1993; 99: 513–25
   PubMed Web of Science ®Google Scholar
• Gralnick H. R., Harbor J., Vogel C. Myelofibrosis in chronic granulocytic leukemia. Blood 1971; 37: 152–162
   PubMed Web of Science ®Google Scholar
• Clough V., Geary C. G., Hashimi K., Davson G., Knowlson T. Myelofibrosis in chronic granulocytic leukaemia. Br. J. Haematol 1979; 42: 515–526
   PubMed Web of Science ®Google Scholar
• Lazzarino M., Morra E., Castello A., Inverardi D., Coci A., Pagnuco G., Magrini U., Zei G., Bernasconi C. Myelofibrosis in chronic granulocytic leukemia. Clinical pathologic correlations and prognostic significance. Br. J. Haematol 1986; 64: 227–240
   PubMed Web of Science ®Google Scholar
• Dekmezian R., Kantarjian H. M., Keating M., Talpaz M., McCredie K. B., Freireich E. J. The relevance of reticulin stain-measured fibrosis at diagnosis in chronic myelogenous leukemia. Cancer 1987; 57: 1739–1743
   Web of Science ®Google Scholar
• Thiele J., Kvasnicka H. M., Titius B. R., Parpert U., Nebel R., Zankovich R., Dienemann D., Stein H., Diehl V., Fischer R. Histological features of prognostic significance in CML - an immunohistochemical and morphomet-ric study (multivariate regression analysis) on trephine biopsies of the bone marrow. Ann. Hematol. 1993; 66: 261–302
   PubMed Web of Science ®Google Scholar
• Thiele J., Kvasnicka H. M., Niederle N., Kloke O., Schmidt M., Lienhard H., Zirbes T., Meuter R. B., Leder L. D., Fischer R. Clinical and histological features retain their prognostic impact under interferon therapy of CML: a pilot study. Am. J. Hematol. 1995; 50: 30–39
   PubMed Web of Science ®Google Scholar
• Adams D. O., Hamilton T. A. The cell biology of macrophage activation. Ann. Rev. Immunol 1984; 2: 283–318
   PubMed Web of Science ®Google Scholar
• Terui T., Niitsu Y., Mahara K., Fujisaki Y., Urushizaki Y., Kohogo Y., Watanabe N., Ogura M., Saito O. The production of transforming growth factor-6 in acute megakaryoblastic leukemia and its possible implication in myelofibrosis. Blood 1990; 75: 1540–1548
   PubMed Web of Science ®Google Scholar
• Reilly J. T., Barnett D., Dolan G., Forrest P., Eastham J., Smith A. Characterization of an acute microme-gakaryocytic leukemia: evidence for the pathogenesis of myelofibrosis. Br. J. Haematol 1993; 83: 58–62
   PubMed Web of Science ®Google Scholar
• Rameshwar P., Denny T. N., Stein D., Gascén P. Monocyte adhesion in patients with bone marrow fibrosis is required for the production of fibrogenic cytokines. J. Immu-nol 1994; 153: 2819–2830
   PubMed Web of Science ®Google Scholar
• Kimura A., Katoh O., Hyodo H., Kuramoto A., Satow Y. Platelet derived growth factor expression, myelofibrosis and chronic myelogenous leukemia. Leukemia Lymphoma 1995; 18: 237–242
   PubMed Web of Science ®Google Scholar
• Martyre M. C. TGF-P and megakaryocytes in the pathogenesis of myelofibrosis in myeloproliferative disorders. Leukemia Lymphoma 1995; 20: 39–44
   PubMed Web of Science ®Google Scholar
• Hayhoe F. G.J., Flemans R. J., Cowling D. C. Acquired lipidosis of marrow macrophages. Birefringent blue crystals and Gaucher-like cells, sea-blue histiocytes, and grey-geen crystals. J. Clin Pathol 1979; 32: 420–428
   PubMed Web of Science ®Google Scholar
• Buesche G., Majewski H., Schlué J., Delventhal S., Baer-Henney S., Vykoupil K. F., Georgii A. Frequency of Pseudo-Gaucher cells in diagnostic bone marrow biopsies from patients with Ph-positive chronic myeloid leukaemia. Virchows Archiv 1997; 430: 139–148
   PubMed Web of Science ®Google Scholar
• Albrecht M. Ergebnissse von Langzeitbeobachtun-gen bei Patienten mit chronisch myeloischer Leukamie. Leukamie, H. Gross, J. van de Loo. Springer Verlag, Heidelberg 1972; 399–404
   Google Scholar
• Kelsey P. R., Geary C. G. Sea-blue histocytes and Gaucher cells in bone marrow of patients with myeloid leukaemia. J. Clin. Pathol 1988; 41: 960–962
   PubMed Web of Science ®Google Scholar
• Schaefer H. E. How to fix, decalcify and stain paraffin embedded bone marrow biopsies. Pathology of the bone marrow, K Lennert, K Huebner. G. Fischer, Stuttgart, New York 1984; 6–9
   Google Scholar
• Gatter K. C., Cordell J. L., Turley H., Heryet A., Kieffer N., Anstee D. J., Mason D. Y. The immunohistologi-cal detection of platelets, megakaryocytes and thrombi in routinely processed specimens. Histopathol. 1988; 13: 256–267
   Web of Science ®Google Scholar
• Falini B., Flenghi L., Pileri S., Gambacorta M., Bigerna B., Duerkop H., Eitelbach E., Thiele J., Pacini R., Cava-Liere A., Martelli M., Cardelli N., Sabatini E., Poggi S., Stein H. PG-M1. A new monoclonal antibody directed against a fixative-resistant epitope on the macroph-age-restricted form of the CD68 molecule. Am. J. Pathol 1993; 142: 1359–1372
   PubMed Web of Science ®Google Scholar
• Tabor D. R., Larry C. H., Jacobs R. F. Differential induction of macrophage GSIB4-binding activity. J. Leukocyte. Biol 1989; 45: 452–457
   PubMed Web of Science ®Google Scholar
• Warfel A. H., Zucker-Franklin D. Specific ligation of surface a-D-galactosyl epitopes markedly affects the quantity of four major proteins secreted by macrophages. J. Leukocyte. Biol. 1992; 52: 80–84
   PubMed Web of Science ®Google Scholar
• Baldus S. E., Thiele J., Park Y. O., Charles A., Mross C., Hanisch F. G., Zirbes T. K., Wickenhauser C., Fischer R. Carbohydrate and peptide antigens in macrophage populations derived from human bone marrow and milk: an immunomorphological and immunohistochemical analysis. Histochem. J. 1995; 27: 630–638
   PubMedGoogle Scholar
• Kaplan E. L., Meier P. Nonparametric estimation from incomplete observations. J. Am. Statist. Ass. 1958; 53: 457–481
   Web of Science ®Google Scholar
• Sokal J. E., Cox E. B., Baccarani M., Tura S., Gomez G. A., Robertson J. D., Tso C. Y., Braun T. J., Clarkson B. D., Cervantes F., Rozman C. the Italian Cooperative CML Study Group. Prognostic discrimination in “good-risk” chronic granulocytic leukemia. Blood 1984; 63: 789–799
   PubMed Web of Science ®Google Scholar
• Kantarjian H., Keating M. J., Smith T. L., Talpaz M., McCredie K. B. Proposal for a simple synthesis prognostic staging system in chronic myelogenous leukemia. Am J. Med. 1990; 88: 1–8
   PubMed Web of Science ®Google Scholar
• Hasford J., Ansari H., Pfirrmann M., Hehlmann R. the German CML Study Group. Analysis and validation of prognostic factors for CML. Bone Marrow Transplant 1996; 17: 49–54
   PubMed Web of Science ®Google Scholar
• Hehlmann R., Ansari H., Hasford J., Heimpel H., Hoss-Feld D. K., Kolb H. J., Loftier H., Pralle H., Queisser W., Reiter A., Hochhaus A. the German CML-Study Group. Comparative analysis of the impact of risk profile and of drug therapy on survival in CML using Sokal's index and a new score. Br. J. Haematol. 1997; 97: 76–85
   PubMed Web of Science ®Google Scholar
• Hasford J., Pfirrmann M., Hehlmann R., Allan N. C., Baccarani M., Kluin-Nelemanns J. C., Alimena G., Steegmann J. L., Ansare H. A new prognostic score for survival of patients with chronic myeloid leukemia treated with interferon alfa. J. Natl. Cancer. Inst. 1998; 90: 850–858
   PubMed Web of Science ®Google Scholar
• Savage D. G., Szydlo R. M., Goldman J. M. Clinical features at diagnosis in 430 patients with chronic myeloid leukaemia seen at a referral centre over a 16-year period. Br. J. Haematol. 1997; 96: 111–116
   PubMed Web of Science ®Google Scholar
• O'Brian S., Kantarjian H., Shtalrid M., Blick M., Beran M., Talpaz M. Lack of breakpoint cluster region rearrangement in marrow fibroblasts of patients with Philidelphia chromosome-positive chronic myelogenous leukemia. Hematol. Pathol. 1988; 2: 25–29
   PubMedGoogle Scholar
• Bhatia R., McGlave P. M., Dewald G. W., Blaza B. R., Verfaillie C. M. Abnormal function of the bone marrow microinvironment in chronic myelogenous leukemia: role of malignant stromal macrophages. Blood 1991; 85: 3636–3645
   Google Scholar
• Bhatia R., Verfaille C. M. The effect of interferon-a on beta-1-integrin mediated adhesion and growth regulation in chronic myelogenous leukemia. Leukemia Lymphoma 1998; 28: 241–254
   PubMed Web of Science ®Google Scholar
• Cervantes F., Rozman C., Piera C., Fernandez M. R. Decreased bone marrow iron in chronic myelogenous leukemia: a consistent finding not reflecting iron deficiency. Blut 1986; 53: 305–308
   PubMedGoogle Scholar
• Sokal J. E., Sheerin K. A. Decreased stainable marrow iron in chronic granulocytic leukemia. Am. J. Med. 1986; 81: 395–399
   PubMed Web of Science ®Google Scholar
• Maddox D. E., Shibata S., Goldstein I. J. Stimulated macrophages express a new glycoprotein receptor reactive with Griffonia simplicifolia I-B4 isolectin. Proc. Natl. Acad. Sci. USA. 1982; 79: 166–170
   PubMed Web of Science ®Google Scholar
• Irimura T., North S. M., Nicolson G. L. Glycoprotein profiles of macrophages at different stages of activation as revealed by lectin binding after electrophoretic separation. Eur. J. Immunol. 1987; 17: 73–78
   PubMed Web of Science ®Google Scholar
• Obinata M., Okuyama R., Matsuda K. I., Koguma M., Yanai N. Regulation of myeloid and lymphoid development of hematopoietic stem cells by bone marrow stromal cells. Leukemia Lymphoma 1998; 29: 61–69
   PubMed Web of Science ®Google Scholar
• Osterholz J., Dowding C., Gou A. P., Siczkowski M., Goldman J. M. Interferon-α alters the distribution of CFU-GM between the adrerent and non-adherent compartments in long-term cultures of chronic myeloid leukemia marrow. Exp. Hematol. 1991; 19: 326–331
   PubMed Web of Science ®Google Scholar
• Dowding C., Gou A. P., Osterholz J., Siczkowski M., Goldman J., Gordon M. Interferon-α overrides the deficient adhesion of chronic myeloid leukemia primitive progenitor cells to bone marrow stromal cells. Blood 1991; 78: 499–505
   PubMed Web of Science ®Google Scholar
• Golde D. W., Burgaleta C., Sparkes R. S., Cline M. J. The Philadelphia chromosome in human macrophages. Blood 1977; 49: 367–370
   PubMed Web of Science ®Google Scholar
• Thiele J., Schmitz B., Fuchs R., Kvasnicka H. M., Loren-Zen J., Fischer R. Detection of the bcr/abl gene in bone marrow macrophages in CML and alterations during interferon therapy - a fluorescence in situ hybridization study on trephine biopsies. J. Pathol. 1998; 186: 331–335
   PubMed Web of Science ®Google Scholar
• Welborn J. L., Lewis J. P. Correlation of marrow iron pattern with disease status of chronic myelogenous leukemia. Leukemia Lymphoma 1993; 10: 469–475
   PubMed Web of Science ®Google Scholar
• Spiers A. S.D. Clinical manifestations of chronic granulocytic leukemia. Semin. Oncol. 1995; 22: 380–395
   PubMed Web of Science ®Google Scholar
• Thiele J., Hoefer M., Kvasnicka H. M., Bertsch H. P., Zank-Ovich R., Fischer R. Erythropoiesis in CML -immunohistomorphometric quantification, PCNA-reactivity, and influence on survival. Hematol., Pathol. 1993; 1: 239–249
   Google Scholar
• Rozman C., Cervantes F., Feliu R. Is the histological classification of chronic granulocytic leukaemia justified from the clinical point of view?. Eur. J. Haematol. 1989; 42: 150–154
   PubMed Web of Science ®Google Scholar
• Cervantes F., Rozman C., Feliu E. Prognostic evaluation of initial bone marrow histopathological features in chronic granulocytic leukemia. Acta. Haemat. 1989; 82: 12–15
   PubMed Web of Science ®Google Scholar